JEFFREY L EDWARDS
CIK 1190642 · EVP, Fin & Bus. Dev., CFO · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$666.8K
Companies
6
Total Filings
58
Lifetime Open-Market Net
-$59.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIO.B | Director | 715 | $304.15 | $217.5K | $0 | 3 | 2026-04-23 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 41,866 | $9.75 | $408.2K | -$135.6K | 11 | 2025-06-06 |
| LFCR | Director | 79,667 | $5.64 | $449.3K | $0 | 5 | 2024-07-10 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | — | $0.35 | — | $0 | 7 | 2024-06-21 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 12,457 | $8.76 | $109.1K | $0 | 5 | 2022-06-07 |
| ALLERGAN INC (AGN) Delisted | EVP, Fin & Bus. Dev., CFO | 58,153 | — | — | -$59.07M | 27 | 2014-02-25 |
Recent Filings · Page 3 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2020-10-16 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2019-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2018-09-28 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-07 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +3,700 | $0 | EDGAR |
| 2017-06-09 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.